Market revenue in 2023 | USD 353.8 million |
Market revenue in 2030 | USD 567.7 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Devices |
Fastest growing segment | Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Devices, Drugs |
Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.08% in 2023. Horizon Databook has segmented the Brazil hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
The Brazilian regulatory body, Agência Nacional de Sade Suplementar (ANS), which is linked to the Ministry of Health, is in charge of regulating the country's insurance providers and private healthcare industry. ANS's main responsibilities include establishing the laws governing private plans and specifying the minimum level of protection that plans must provide to affiliates or around 22% of the Brazilian population.
ANS Rol outlines the minimal mandatory coverage of services (diagnostics, procedures, and treatments) that private payers are required to provide. Over 3,000 medical procedures, diagnostic tests, drugs, and other medical services are included in a list that is frequently updated.
In Brazil, hearing loss treatment is generally covered by the national healthcare system, known as the Unified Health System (SUS). This includes coverage for hearing aids, cochlear implants, and other hearing loss treatments, although patients may need to pay out-of-pocket expenses to access more advanced or expensive treatments.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Brazil hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account